Table 2.
Demographic and comorbidity characteristics of the cohort (657 patients).
| Variable | N = 657 | 95% CI |
|---|---|---|
| M (n(%)) | 355 (54.03) | 50.21–57.81 |
| F (n (%)) | 302 (45.97) | 42.19–49.79 |
| Average age (average (IQR)) | 62.38 (53–73) | / |
| Comorbid conditions | ||
| Peripheral artery disease (n (%)) | 61 (9.28) | 7.30–11.75 |
| Hypertensive patients (n (%)) | 112 (17.04) | 14.37–20.11 |
| SARS-CoV2 (n (%)) | 106 (16.13) | 13.52–19.14 |
| Diabetes mellitus (n (%)) | 69 (10.5) | 8.38–13.08 |
| Coronary artery disease (n (%)) | 43 (6.54) | 4.90–8.70 |
| Ischemic stroke (n (%)) | 41 (6.24) | 4.63–8.36 |
| Kidney stones (n (%)) | 9 (1.37) | 0.72–2.58 |
| Chronic kidney disease (CKD) (n (%)) | 47 (7.15) | 5.42–9.38 |
| Acute kidney injury (AKI) (n (%)) | 39 (5.93) | 4.37–8.01 |
| Renal neoplasia (n (%)) | 7 (1.06) | 0.52–2.18 |
| Cirrhosis (n (%)) | 61 (9.28) | 7.30–11.75 |
| Biliary lithiasis (n (%)) | 50 (7.61) | 5.82–9.89 |
| GI tract neoplasia (n (%)) | 53 (8.06) | 6.22–10.40 |
Legend: GI—gastrointestinal.